AVPT CEO option exercises; holds 2,153,502 shares after trades

AvePoint (AVPT) disclosed an insider transaction by its Chief Executive Officer and director on 10/17/2025.

Rhea-AI Filing Summary

AvePoint (AVPT) disclosed an insider transaction by its Chief Executive Officer and director on 10/17/2025. The reporting person exercised stock options and acquired common shares in three transactions: 299,435, 158,634, and 37,974 shares, at exercise prices of $1.34, $1.59, and $3.91, respectively. After these exercises, the reporting person beneficially owned 2,153,502 shares, held directly.

The holdings reflect common stock and restricted stock units granted under AvePoint’s equity incentive plans, as noted in the footnotes.

Insider Trade Summary

496,043 shares exercised/converted

Exercise 6 txns

Insider Jiang Tianyi

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	299,435	$0.00	$0.00
Exercise	Stock Option (Right to Buy)	158,634	$0.00	$0.00
Exercise	Stock Option (Right to Buy)	37,974	$0.00	$0.00
Exercise	Common Stock	299,435	$14.08	$4.22M
Exercise	Common Stock	158,634	$14.08	$2.23M
Exercise	Common Stock	37,974	$14.08	$535K

Holdings After Transaction: Stock Option (Right to Buy) — 7,746,765 contracts (Direct); Common Stock — 2,153,502 shares (Direct)

Footnotes (3)

1. F1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
2. F2. These securities represent options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan that have been exercised.
3. F3. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did AVPT report?

The CEO and director exercised stock options on 10/17/2025 and acquired common shares in three transactions.

How many AVPT shares were acquired through option exercises?

Three exercises converted into 299,435, 158,634, and 37,974 common shares.

What were the exercise prices for the AVPT options?

The options were exercised at $1.34, $1.59, and $3.91.

How many AVPT shares does the insider own after the transactions?

Beneficial ownership after the reported transactions is 2,153,502 shares, held directly.

What roles does the reporting person hold at AvePoint (AVPT)?

The reporting person is a Chief Executive Officer and a Director.

Do the reported AVPT holdings include RSUs?

Yes. Footnotes state holdings include common stock and RSUs granted under company equity plans.

Were these AVPT transactions part of a 10b5-1 plan?

The provided excerpt does not indicate the 10b5-1 plan box was checked.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/21/2025 - 07:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jiang Tianyi

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	10/17/2025		M		299,435(2)	A	$14.08	1,956,894	D
Common Stock(1)	10/17/2025		M		158,634(2)	A	$14.08	2,115,528	D
Common Stock(1)	10/17/2025		M		37,974(2)	A	$14.08	2,153,502(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.34	10/17/2025		M			299,435	07/01/2020	07/01/2026	Common Stock	299,435	$0	2,700,669	D
Stock Option (Right to Buy)	$1.59	10/17/2025		M			158,634	01/10/2023	01/10/2029	Common Stock	158,634	$0	2,542,035	D
Stock Option (Right to Buy)	$3.91	10/17/2025		M			37,974	08/12/2024	08/12/2030	Common Stock	37,974	$0	2,504,061	D

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. These securities represent options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan that have been exercised.

3. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025.

	/s/ Brian Michael Brown, Attorney-in-Fact	10/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.